La. Judge Stays Discovery as to Teva in Metoclopramide Action, Finding Plaintiff Most Likely Did Not Ingest Its Product
November 27, 2013
DOCUMENTS
- Order
NEW ORLEANS — A Louisiana federal magistrate judge has granted Teva Pharmaceuticals USA Inc.’s motion for a protective order staying discovery as to the drug maker in a metoclopramide injury action, finding the drug ingested by the plaintiff was most likely not made by Teva.
On Nov. 19, Magistrate Judge Karen Wells Roby of the U.S. District Court for the Eastern District of Louisiana noted that the pharmacy history sheet attached to Teva's indicates that Lindsey Whitener ingested "metoclopramide" manufactured by PLIVA, and not Teva, during the relevant time.
Lindsey Whitener was prescribed metoclopramide while she was pregnant to treat …
FIRM NAMES
- Barrasso, Usdin, Kupperman, Freeman & Sarver
- Goodwin Procter
- J.H. Barney Firm
- Smith Law Firm
- The Aubert Law Firm
- Ulmer & Berne
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick